The European ALARA Network
The European ALARA Network (EAN) promotes the optimisation of radiation protection (keeping exposures As Low As Reasonably Achievable – ALARA) across Europe. It brings together professionals, regulators, and stakeholders to share experience, develop guidance, and support the practical implementation of ALARA principles in various sectors, including industry, medicine, research, and the environment.
0
0
0
s2sdefault
powered by social2s

Programme and downloadable presentations

Paper Title, Authors
  Official welcome
Mr Fergus O'Dowd RD, Minister of State at the Department of Communications, Energy & Natural Resources and Environment, Community & Local Government
  Session 1a - Introduction and Scene Setting 
Chairperson: Ann McGarry (RPII, Ireland)
  Introduction
Ann McGarry (RPII)
1a.1 The European ALARA Network
Fernand Vermeersch (EAN chairperson)
1a.2 Existing exposure situations: challenges and the current work of ICRP
Chris Clement (ICRP Scientific Secretary)
1a.3 EC progress regarding building material and radon risks
Stéphane Calpéna (European Commission)
  Session 1b  - Introduction and scene setting 
Chairperson: Fernand Vermeersch (EAN)
1b.1 Radiological protection decision making in existing exposure situations - an NEA viewpoint on stakeholder involvement
Ted Lazo (NEA)
1b.2 Applications of the international Basic Safety Standards to existing exposure situations
P.P. Haridasan (IAEA)
1b.3 Developing a national radon strategy for Ireland
David Fenton (RPII, Ireland)
1b.4 New perspectives and issues arising from the introduction of NORM residues in building materials
Christina Nuccetelli (ISS, Italy)
1b.5 The ALARA NORM Network - contribution to reducing radiation exposure at NORM workplaces
Karin Wichtery (BfS, Germany)
  Session 2a - Optimisation
Chairperson: Ted Lazo (NEA)
2a.1 Application of ALARA to cosmic ray exposures
Werner Ruehm (Helmholtz Zntrum München, Germany)
2a.2 Managing radiation risks from point sources
James Gemmill (SEPA, UK)
2a.3 Contaminated goods and foodtuffs
Jean François Lecomte (IRSN, France)
2a.4 Introduction to Working Group sessions
Peter Shaw (EAN secretary)
  Session 2b - Optimisation
Chairperson: Chris Clement (ICRP)
2b.1 Radiation protection during the remediation of radioactive contaminated sites on former industrially used sites
Rainer Gellerman (Nuclear Control & Consulting GmbH, Germany)
2b.2 Ethics and social values in the management of existing exposure situations
Jacques Lochard (CEPN, France)
2b.3 Application of health economics in the development of a national radon control strategy in Ireland
David Pollard (RPII, Ireland)
2b.4 HPA contaminated land radiation protection framework
Joanne Brown (HPA, UK)
2b.5 Existing exposure situations: intervention in practice
Ciaran McDonnell (HPA, UK)
  Session 3a - Stakeholders involvement and responsibilities
Chairperson: Jacques Lochard (CEPN)
3a.1 Aircraft crew exposures from 2004 - 2009 in Germany
Gerhard Frasch (BfS, Germany)
3a.2 Building ALARA culture as a tool for effective risk communication
Sotirios Economides (GAEC, Greece)
3a.3 Radon: raising awareness, promoting action
Mark Brennock (Murrays consultants, Ireland)
3a.4 The role of reference levels in removing long-term controls: Post-Chernobyl sheep restrictions in the UK
Christopher Thomas (FSA, UK)
3a.5 Experience from a high radon area in Norway
Anne Liv Rudjord (NRPA, Norway)
  Session 3b - Stakeholders involvement and responsibilities
Chairperson: Ian McAulay (former member of EC article 31 GoE)
3b.1 A pluralistic and multi-disciplinary approach to post-accidental management: the CODIRPA French program
Florence Gallay (ASN, France)
3b.2 The Montbéliard experience with managing radon
Sandra Biguenet (CEPN, France)
  Session 4 - Conclusions and recommendations
Chairpersons: Peter Shaw, Pascal Croüail (EAN)
4.1 Report from the Working Group 1: ALARA challenges and practicalities at the national and regional level (The PPT is the result of the Working Group discussions. It has not been modified by the Editorial Team)
4.2 Report from the Working Group 2: Considerations in chooding dose reference levels (The PPT is the result of the Working Group discussions. It has not been modified by the Editorial Team)
4.3 Report from the Working Group 3:Economic and technical factors, and endpoints of optimisation (The PPT is the result of the Working Group discussions. It has not been modified by the Editorial Team)
4.4 Report from the Working Group 4: Societal factors and stakeholder engagement (The PPT is the result of the Working Group discussions. It has not been modified by the Editorial Team)
4.5 Conclusions and recommendations